AAAS names 7 Washington University faculty as 2020 fellows
Seven faculty members at Washington University in St. Louis are among 489 new fellows selected by the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society.
Innovative training program boosts expertise in putting cancer research into practice
Washington University’s Mentored Training for Dissemination and Implementation Research in Cancer program, the first of its kind in cancer prevention and control, has resulted in an uptick in skills, grants, publications, networking and even some practice changes.
Young people with disabilities focus of COVID-19 testing grant
School of Medicine researchers have received a grant allowing them to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County.
Lethal brain infections in mice thwarted by decoy molecule
School of Medicine scientists have identified a molecule that protects mice from brain infections caused by Venezuelan equine encephalitis virus, a mosquito-borne virus notorious for causing fast-spreading, deadly outbreaks in Mexico, Central America and northern South America.
Siegel receives honor from American College of Radiology
Barry A. Siegel, MD, professor of radiology and of medicine at Washington University School of Medicine in St. Louis, has received the Gold Medal Award from the American College of Radiology for his more than 40 years of leadership in the nuclear medicine community.
Obituary: Karen Seibert, executive director of pharmacology center, 61
Karen Seibert, a deeply respected leader in pharmacology at Washington University School of Medicine in St. Louis, died Monday, Nov. 9, 2020, at her home in Chesterfield, Mo., after a battle with a cancer. She was 61.
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
A study led by School of Medicine researchers showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.
Fluvoxamine may prevent serious illness in COVID-19 patients
Researchers at Washington University School of Medicine have found that the drug fluvoxamine may help prevent deterioration in COVID-19 patients, making hospitalization less likely.
For all ages
What would a truly intergenerational community look like? Three WashU scholars explain how a community can become more accessible for people of every age.
Making cancer cells more susceptible to dying
Cancer cells can survive even after being hit with high doses of chemotherapy or radiation, but a School of Medicine team working to make treatment more effective is focusing on ways to tweak the inner machinery of cancer cells to make them more susceptible to dying.
View More Stories